Lao People's Democratic Republic (the)

in page functions
[French]
Lao PDR
Total population (2018) 7,158,227
Birth cohort (2018) 178,575
Surviving Infants (surviving to 1 year per year, 2018) 171,930
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 51/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 67/1000
World Bank Index, IDA (2015) 3.29
Gross Nation Income (per capita US$, 2015) 1,740
Co-financing group (2018) Accelerated transition
No. of districts/territories (2017) 148

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Lao PDR

Type of support

Approvals

2001-2023 (US$)
(28 Nov 2018)

Commitments

2001-2023 (US$)
(28 Nov 2018)

Disbursements

2000-2018 (US$)
(28 Nov 2018)

% Disbursed

(28 Nov 2018)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Total $45,017,003 $51,319,503 $39,535,721
Cash Support (CASHSUPP) $196,500 $221,500 $196,500 100%
Graduation grant (GG) $1,534,394 $1,534,394 $1,355,894 88%
Health system strengthening (HSS 1) $438,500 $438,500 $438,500 100%
Health system strengthening (HSS 2) $4,389,698 $4,389,698 $4,389,698 100%
Health system strengthening (HSS 3) $5,400,000 $9,000,000 $3,555,846 66%
Health system strengthening (HSS 3 - PBF) N/A
HepB mono (NVS) $82,855 $82,855 $82,855 100%
HPV (NVS) $746,500 $2,361,500
HPV Demo (NVS) $564,181 $564,181 $592,698 105%
HPV MAC (NVS) $2,503,500 $2,503,500
HPV MAC - Op costs (OPC) $134,667 $134,667
Immunisation services support (ISS) $1,431,200 $1,431,200 $1,431,200 100%
Injection Safety Devices (NVS) $172,500 $219,000 $102,561 59%
Injection safety support (INS) $255,505 $255,505 $255,505 100%
IPV (NVS) $1,776,571 $1,776,571 $1,313,510 74%
JEV (NVS) $625,592 $625,592 $625,968 100%
JEV - Operational costs (OPC) $1,047,500 $1,047,500 $1,047,500 100%
MR 1st and 2nd dose (NVS) $300,500 $412,500 $164,412 55%
MR 2nd dose (NVS) $75,090 $75,090 $75,090 100%
Penta (NVS) $9,201,188 $9,429,188 $9,837,293 107%
Pneumo (NVS) $9,121,707 $9,797,707 $9,237,747 101%
Product Switch Grant (PSG) $45,000 $45,000 $45,000 100%
Rotavirus (NVS) N/A
Tetra DTP-HepB (NVS) $3,837,114 $3,837,114 $3,837,114 100%
Vaccine Introduction Grant (VIG) $1,136,741 $1,136,741 $950,830 84%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Lao PDR DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 85%
M:F sex ratio at birth (2018) 1.05
Household survey: DTP3 coverage for male (2010) 52.00%
Household survey: DTP3 coverage for female (2010) 53.10%
Household survey: Last DTP3 survey (2014) 81%
% districts achieving > 80% DTP3 coverage (2017) 64%
% districts achieving < 50% DTP3 coverage (2017) 5%
MCV WHO/UNICEF estimates (2017) 82%

Breakdown of support

Non-vaccine support Vaccine support
35% 65%
$13,666,473 $25,869,248

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Lao PDR

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

29 November 2017

Anuradha Gupta, Ngozi Okonjo Iweala, Seth Berkley, Bounkong Syhavong and Somdy Duangby

Gavi and its representatives awarded Medals of labour by Lao PDR president

Gavi honoured for their contribution to immunisation and health system strengthening in the country

29 November 2017

CEO Board update November 2017

Dr Seth Berkley presents an update to the Gavi Board meeting in Vientiane, Lao PDR, reporting on key developments in the global landscape, previous Board decisions and strategic discussion topics.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here